Press Releases
Calidi is at the forefront of the genetic medicine revolution in cancer and other indications
Read the Latest
Calidi Biotherapeutics Announces Appointment of Andrew Jackson as Chief Financial Officer
SAN DIEGO–(BUSINESS WIRE)– Calidi Biotherapeutics, Inc. (NYSEAM: CLDI) (or “Calidi”), a clinical-stage biotechnology company developing…
Calidi Biotherapeutics To Present New Preclinical Data Highlighting Cell-based Virotherapy (SuperNova) Platform Technology at SITC 2023
SAN DIEGO–(BUSINESS WIRE)– Calidi Biotherapeutics, Inc. (NYSE American: CLDI or “Calidi”), a clinical-stage biotechnology company…
Analyst Bullish On Calidi Biotherapeutics, Newly Listed Cancer Treatment Player
Calidi Biotherapeutics: A Promising Player in the Cancer Treatment Market
Calidi Biotherapeutics Debuts as a Publicly Traded Company Focused on Arming the Immune System to Fight Cancer with a New Generation of Targeted Immunotherapies
Business combination transaction with First Light Acquisition Group, a special purpose acquisition company, completed on…
Calidi Biotherapeutics to Present at Baird’s Global Healthcare Conference
SAN DIEGO–(BUSINESS WIRE)–Calidi Biotherapeutics, Inc., (approved for listing on NYSE American under “CLDI”), a clinical-stage…